Sedative Effects in Obstructive Sleep Apnea

Trial Profile

Sedative Effects in Obstructive Sleep Apnea

Withdrawn prior to enrolment
Phase of Trial: Phase II/III

Latest Information Update: 22 Jun 2015

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Sleep apnoea syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 May 2013 Planned end date changed from 1 Aug 2013 to 1 Aug 2014 as reported by ClinicalTrials.gov.
    • 31 May 2013 Planned initiation date changed from 1 Jan 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.
    • 03 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top